Eliot Forster

Filings by Eliot Forster span 2 companies, the busiest being F-star Therapeutics, Inc. and Protalix BioTherapeutics, Inc. The record holds 3 filings, for trades running from 29 July 2022 to 3 September 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 4 September 2025 came the latest disclosure, a share grant in Protalix BioTherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.